A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT... von Pilz, Stefan, Gekkieva, Margarita, Reynders, Stefaan, Perez-Salvador Garcia, Eduardo, Lipkova, Blandina, Beatty, Stephen, Pagliarini, Sergio, Si Bouazza, Abdelkader

Volltext

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study von Schmidt-Erfurth, Ursula, Lang, Gabriele E, Holz, Frank G, Schlingemann, Reinier O, Lanzetta, Paolo, Massin, Pascale, Gerstner, Ortrud, Bouazza, Abdelkader Si, Shen, Haige, Osborne, Aaron, Mitchell, Paul

Volltext

Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema von Schmidt-Erfurth, Ursula, MD, Lang, Gabriele E., MD, Holz, Frank G., MD, Schlingemann, Reinier O., MD, Lanzetta, Paolo, MD, Massin, Pascale, MD, PhD, Gerstner, Ortrud, MSc, Bouazza, Abdelkader Si, Shen, Haige, PhD, Osborne, Aaron, MD, Mitchell, Paul, MD, PhD

Volltext

A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT... von Sergio Pagliarini, Stephen Beatty, Blandina Lipkova, Eduardo Perez-Salvador Garcia, Stefaan Reynders, Margarita Gekkieva, Abdelkader Si Bouazza, Stefan Pilz

Volltext